Microsoft selbst warnt vor der Verwendung von Internet Explorer, da er nicht mehr den neuesten Web- und Sicherheitsstandards entspricht. Wir können daher nicht garantieren, dass die Seite im Internet Explorer in vollem Umfang funktioniert. Nutze bitte Chrome oder Firefox.

AstraZeneca Proposes a Merger With Gilead Sciences

TheMotleyFool

0 0

AstraZeneca Proposes a Merger With Gilead SciencesPhoto, wide shot, wide-angle lens, Biotech company, Blue hour, twilight, cool, ISO1200, slow shutter speed, photo by Sebastião Salgado: https://img.theapi.app/temp/80e18bfd-1ff8-4487-af62-1cdb7de1ceb6.png

The coronavirus pandemic put a stranglehold on big pharma dealmaking, but it looks like the logjam's about to break. AstraZeneca (NYSE: AZN) has spoken with Gilead Sciences (NASDAQ: GILD) about forming a gigantic biopharmaceutical powerhouse.

People familiar with the matter told Bloomberg that the big British drugmaker informally floated the idea with Gilead in May to gauge interest. No terms have been discussed, but this would be the largest deal the healthcare sector has ever seen.

Image source: Getty Images.

Source Fool.com

Like: 0

GILD

Teilen